The incidence of cutaneous melanoma is growing worldwide; age-adjusted incidence rates have been increasing in most fair-skinned populations for several decades. In the United States, 150 000 cases per year are projected by 2030.1 Although melanoma has relatively good survival rates, it remains a major cause of cancer deaths and, as the most common cancer in young adults, it contributes to significant premature loss of life. The American Cancer Society estimates 10 130 melanoma deaths in the United States in 2016. Primary prevention and early detection are important strategies to reduce the burden of melanoma, but questions remain about where to focus such efforts.
Emery JD, Usher-Smith JA, Walter FM. Predicting the Risk of Melanoma. JAMA Dermatol. 2016;152(8):875-877. doi:10.1001/jamadermatol.2016.1574